Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Background: Several per- and polyfluoroalkyl substances (PFAS) are ubiquitous anthropogenic pollutants almost universally detected in humans. Experimental evidence indicates that PFAS alter glucose metabolism and insulin secretion. However, epidemiological studies have yielded inconsistent results. Objective: We sought to examine associations between plasma PFAS concentrations, glycemic indicators, and diabetes incidence among high-risk adults. Methods: Within the Diabetes Prevention Program (DPP), a trial for the prevention of type 2 diabetes among high-risk individuals, we quantified baseline plasma concentrations of nine PFAS among 957 participants randomized to a lifestyle intervention or placebo. We evaluated adjusted associations for plasma PFAS concentrations with diabetes incidence and key glycemic indicators measured at baseline and annually over up to 4.6 y. Results: Plasma PFAS concentrations were similar to those reported in the U.S. population in 1999–2000. At baseline, in cross-sectional analysis, a doubling in plasma perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) concentrations was associated with higher homeostatic model assessment of insulin resistance (HOMA-IR) [βPFOS=0.39; 95% confidence interval (CI): 0.13, 0.66; βPFOA=0.64; 95% CI: 0.34, 0.94], β-cell function (HOMA-β) (βPFOS=9.62; 95% CI: 1.55, 17.70; βPFOA=15.93; 95% CI: 6.78, 25.08), fasting proinsulin (βPFOS=1.37 pM; 95% CI: 0.50, 2.25; βPFOA=1.71 pM; 95% CI: 0.72, 2.71), and glycated hemoglobin (HbA1c) (βPFOS=0.03%; 95% CI: 0.002, 0.07; βPFOA=0.04%; 95% CI: 0.001, 0.07). There was no strong evidence of associations between plasma PFAS concentrations and diabetes incidence or prospective changes in glycemic indicators during the follow-up period. Conclusions: At baseline, several PFAS were cross-sectionally associated with small differences in markers of insulin secretion and β-cell function. However, there was limited evidence suggesting that PFAS concentrations are associated with diabetes incidence or changes in glycemic indicators during the follow-up period. https://doi.org/10.1289/EHP1612
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“However, the production of PFOS, PFOA, and other PFAS precursors continues to increase in China and continental Asia (Jin et al. 2007; Land et al. 2015; Xie et al. 2013).”
Buck, R. C., Franklin, J., Berger, U., Conder, J. M., Cousins, I. T., de Voogt, P., Jensen, A. A., Kannan, K., Mabury, S. A., & van Leeuwen, S. P. (2011) · Integrated Environmental Assessment and Management · doi:10.1002/ieam.258 · Cited by 4,641
Estimation of Average Concentration in the Presence of Nondetectable Values
Hornung, R. W., & Reed, L. D. (1990) · Applied Occupational and Environmental Hygiene · doi:10.1080/1047322x.1990.10389587 · Cited by 3,495
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · cited 1×
“For example, DuPont Washington Works workers occupationally exposed to some PFAS had an increased risk in mortality from diabetes compared to other workers (Leonard et al. 2008).”
Sources, fate and transport of perfluorocarboxylates
Prevedouros, K., Cousins, I. T., Buck, R. C., & Korzeniowski, S. H. (2006) · Environmental Science & Technology · doi:10.1021/es0512475 · Cited by 2,594
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049 · cited 1×
“PFAS also have long elimination half-lives in humans, estimated to range from 3.5 to 8.5 y, depending on the compound (Olsen et al. 2007).”
Influential(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)
Steenland, K., Fletcher, T., & Savitz, D. A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901827 · Cited by 660
Nelson, J. W., Hatch, E. E., & Webster, T. F. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901165 · Cited by 538 · cited 13×
“Conversely, in a Danish cohort of children, higher PFOS and PFOA plasma concentrations were cross-sectionally associated with higher HOMA-IR and HOMA-b among overweight children (Timmermann et al. 2014).”
InfluentialSelf-citationHanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463 · cited 1×
“These two measures re fl ect insulin secretion and b -cell function more accurately (Hanson et al. 2000; Herzberg-Schäfer et al. 2010).”
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446 · cited 1×
“As previously demonstrated in the DPP, the e ff ect of the life-style intervention was strongly associated with diabetes incidence and had a large in fl uence on metabolic and glycemic markers over time (Kitabchi et al. 2005).”
Halldorsson, T. I., Rytter, D., Haug, L. S., Bech, B. H., Danielsen, I., Becher, G., Henriksen, T. B., & Olsen, S. F. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104034 · Cited by 353 · cited 1×
“A prospective study found that higher prenatal plasma PFOA concentrations were associated with increased overweight prevalence and greater waist circumference in females but not male o ff spring at age 20 y (Halldorsson et al. 2012).”
Ammonium Perfluorooctanoate Production and Occupational Mortality
Lundin, J. I., Alexander, B. H., Olsen, G. W., & Church, T. R. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181b5f395 · Cited by 156 · cited 1×
“Similarly, another occupationally exposed population had a higher than expected risk of diabetes-related deaths compared to nonexposed workers (Lundin et al. 2009).”
Leonard, R. C., Kreckmann, K. H., Sakr, C. J., & Symons, J. M. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.06.011 · Cited by 147 · cited 1×
“…sample from NHANES 1999 – 2000 and 2003 – 2004, higher serum PFNA was associated with hyperglycemia but with lower risk of metabolic syndrome, while PFOA was associated with higher b -cell function, and PFOS was associated with higher insulin, HOMA-IR, and b -cell function (Lin et al. 2009).”
Zhang, C., Sundaram, R., Maisog, J., Calafat, A. M., Barr, D. B., & Buck Louis, G. M. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.10.001 · Cited by 135
Self-citationCirculating levels of perfluoroalkyl substances and prevalent diabetes in the elderly
Lind, L., Zethelius, B., Salihovic, S., van Bavel, B., & Lind, P. M. (2014) · Diabetologia · doi:10.1007/s00125-013-3126-3 · Cited by 128
Polyfluorinated Compounds in Serum Linked to Indoor Air in Office Environments
Fraser, A. J., Webster, T. F., Watkins, D. J., Nelson, J. W., Stapleton, H. M., Calafat, A. M., Kato, K., Shoeib, M., Vieira, V. M., & McClean, M. D. (2012) · Environmental Science & Technology · doi:10.1021/es2038257 · Cited by 127 · cited 1×
“Human exposure to PFAS occurs mainly through the consumption of contaminated food and drinking water, or exposure to dust and commercial products such as food packaging containing PFAS (D ’ eon and Mabury 2011; Fraser et al. 2011).”
Self-citationYan, S., Zhang, H., Zheng, F., Sheng, N., Guo, X., & Dai, J. (2015) · Scientific Reports · doi:10.1038/srep11029 · Cited by 110 · cited 1×
“In mice, PFOA exposure altered normal glucose metabolism and increased insulin sensitivity (Yan et al. 2015).”
Early-life exposure to perfluoroalkyl substances and childhood metabolic function
Fleisch, A. F., Rifas-Shiman, S. L., Mora, A. M., Calafat, A. M., Ye, X., Luttmann-Gibson, H., Gillman, M. W., Oken, E., & Sagiv, S. K. (2017) · Environmental Health Perspectives · doi:10.1289/ehp303 · Cited by 91
Self-citation
Cited by
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
Risk to human health related to the presence of perfluoroalkyl substances in food
Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989
Yilmaz, B., Terekeci, H., Sandal, S., & Kelestimur, F. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09521-z · Cited by 748
PFAS Environmental Pollution and Antioxidant Responses: An Overview of the Impact on Human Field
Bonato, M., Corrà, F., Bellio, M., Guidolin, L., Tallandini, L., Irato, P., & Santovito, G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218020 · Cited by 243
Metadata
- Authors
- Cardenas, A., Gold, D. R., Hauser, R., Kleinman, K. P., Hivert, M.-F., Calafat, A. M., Ye, X., Webster, T. F., Horton, E. S., & Oken, E.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-10-03
- Volume
- 125
- Issue
- 10
- Pages
- 107001-107001
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2762019316
- Cited by
- 146
- References
- 20
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.